DSIP is a neuropeptide studied for its potential to promote deep, restorative sleep by enhancing delta wave activity. Typically administered subcutaneously in research settings, dosages range from 100 to 250 mcg, adjusted based on individual response. Researchers are advised to start with the lowest effective dose and monitor for any adverse reactions.
7 in stock
May enhance deep, restorative sleep by promoting delta wave activity
Administered subcutaneously; dosages typically range from 100–250 mcg
Potential benefits in mood regulation and stress reduction
Under investigation for applications in sleep disorders and neuroendocrine research
All products offered on this website are strictly intended for research and development purposes only. They are not for human consumption in any form.
The statements presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
Superhuman Peptides operates solely as a chemical supplier. It is not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Superhuman Peptides is also not an outsourcing facility as defined under Section 503B of the same Act.
This website contains information about supplementary products. By entering, you confirm that you are of legal age (18 years or older) to access this information. If you are not of legal age, please leave this site immediately.
